Gelonghui, January 29丨Guoxin Health (000503.SZ) announced its 2023 annual results forecast. The net profit loss attributable to shareholders of listed companies during the reporting period was approximately RMB 80.45 million, with a loss of 84.47 million yuan during the same period of the previous year; net profit loss after deducting non-recurring profit and loss of about RMB 123.46 million, loss of 117.81 million yuan for the same period last year; basic earnings loss per share was about 0.0883 million yuan per share; operating income was approximately RMB 31.08 million after deduction.
During the reporting period, the company firmly established the “two wings of one” strategic layout. On the one hand, it focused on improving the professional service capabilities of the “one”, or digital health insurance sector, and consolidating its position in the industry; on the other hand, it accelerated investment in the “two wings”, or digital medicine sectors, and continuously optimized and improved the product system. During the reporting period, the company's overall operating conditions improved steadily, achieving revenue of about RMB 330 million, a year-on-year growth rate of about 6.08%; net profit of RMB 80.98 million, a decrease of 4.13% over the previous year.
